Observational studyDiagnostic pathology2017

Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy.

Balázs Ács et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.